Jesy Nelson’s Twins Diagnosed with SMA Type 1: What You Need to Know

Spinal muscular atrophy (SMA) has gained attention following the announcement that British singer and television personality Jesy Nelson revealed her twin daughters, Ocean Jade and Story Monroe Nelson-Foster, have been diagnosed with SMA type 1. This rare genetic condition affects the body’s ability to move, leading to severe muscle weakness and potentially life-threatening complications.

SMA is classified into five subtypes, with type 1, also known as Werdnig-Hoffman disease, accounting for approximately 60 percent of cases. Symptoms typically manifest within the first six months of life, presenting challenges such as difficulty swallowing and breathing. Without intervention, life expectancy for children with SMA type 1 often falls below two years.

Understanding Spinal Muscular Atrophy

This inherited neuromuscular disorder primarily impacts the lower motor neurons in the spinal cord, which are essential for muscle movement. When these nerve cells degenerate, the muscles cease to receive the necessary signals, resulting in progressive weakness. The muscles closest to the body’s center, such as those governing the head, neck, chest, and legs, are particularly affected.

According to estimates, SMA occurs in about one in every 6,000 to one in 11,000 live births, making it one of the most common severe inherited conditions in infants and children. The condition is notably more prevalent in white and Asian populations compared to Black and Hispanic populations.

SMA is inherited in an autosomal recessive pattern, meaning both parents must be carriers of a mutated SMN1 gene for a child to be affected. Most carriers do not exhibit symptoms, with about one in 50 people in white populations being carriers. Genetic testing confirms SMA in around 95 percent of cases, often following physical and neurological assessments.

Jesy Nelson’s Personal Journey

In an emotional Instagram video, Jesy Nelson shared her daughters’ diagnosis, explaining that the twins were not moving their legs as anticipated and struggled with feeding. After extensive medical consultations, they were assessed at Great Ormond Street Hospital in London. Doctors informed Nelson that her daughters would “probably never be able to walk” and would likely not regain neck strength.

She emphasized the comprehensive impact of SMA, stating, “SMA does affect every muscle in the body, down to legs, arms, breathing, swallowing.” Following their diagnosis, the twins have begun treatment, which Nelson described as essential for their survival. She remarked, “Because if they don’t have it, they will die.”

Treatment for SMA typically involves managing symptoms and preventing complications. This may include physical and occupational therapy, feeding support, and medications designed to boost SMN protein production. In recent years, advancements in gene replacement therapy and disease-modifying drugs have significantly improved outcomes, especially for infants with SMA type 1.

Nelson’s decision to share her daughters’ diagnosis stems from a desire to raise awareness and promote early diagnosis, which can lead to timely intervention. “The last three months have honestly been the most heartbreaking time of my life,” she said, expressing hope that with appropriate care, her daughters will “defy all the odds.”

As awareness of SMA increases, potential parents are encouraged to consider genetic testing if there is a family history of the condition. Carrier testing can identify individuals who may carry the altered gene, allowing for informed family planning and access to genetic counseling.

Through her openness about this difficult journey, Jesy Nelson is not only highlighting the challenges faced by families affected by SMA but also advocating for the importance of early diagnosis and treatment options.